scholarly journals Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial

2015 ◽  
Vol 14 (1) ◽  
Author(s):  
Richard L. Dunbar ◽  
Stephen J. Nicholls ◽  
Kevin C. Maki ◽  
Eli M. Roth ◽  
David G. Orloff ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
High Risk ◽  
Carboxylic Acids ◽  
Risk Markers ◽  
Double Blind Trial ◽  
Omega 3 ◽  
Double Blind ◽  
Blind Trial ◽  
Lipoprotein Particles ◽  
Randomized Controlled

320: Can we find the perfect oil to protect the perineum? A randomized-controlled double-blind trial

2009 ◽  
Vol 201 (6) ◽  
pp. S127-S128 ◽  
Author(s):  
Avi Harlev ◽  
Barak Aricha-Tamir ◽  
Roy Kessous ◽  
Savyona Ben Ayun ◽  
Arnon Wiznitzer ◽  
...  
Keyword(s):  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial ◽  
Randomized Controlled

Safety of essential bee venom pharmacopuncture as assessed in a randomized controlled double-blind trial

2016 ◽  
Vol 194 ◽  
pp. 774-780 ◽  
Author(s):  
Yong-jun Ahn ◽  
Joon-Shik Shin ◽  
Jinho Lee ◽  
Yoon Jae Lee ◽  
Me-riong Kim ◽  
...  
Keyword(s):  
Bee Venom ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial ◽  
Randomized Controlled

A randomized controlled double-blind trial comparing piritramide and morphine for analgesia after hysterectomy

2001 ◽  
Vol 18 (6) ◽  
pp. 389-393 ◽  
Author(s):  
U. R. Döpfmer ◽  
M. R. Schenk ◽  
S. Kuscic ◽  
D. H. Beck ◽  
S. Döpfmer ◽  
...  
Keyword(s):  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial ◽  
Randomized Controlled

Normalization By Suloctidil Of Decreased Platelet Survival In Patients With Heart Prosthetic Valves In Randomized Controlled Double Blind Trial

1981 ◽  
Author(s):  
N Ciavarella ◽  
S Antoneecchit ◽  
N D’Elia ◽  
P Ranieri ◽  
A Manzini
Keyword(s):  
Double Blind Trial ◽  
Anticoagulant Treatment ◽  
Double Blind ◽  
Blind Trial ◽  
Randomized Controlled ◽  
Prosthetic Valves ◽  
Platelet Survival

Platelets play an important role in thromboembo lie episodes in the life of patients with heart prosthetic valves. Decreased platelet survival and increased B-Tromboglobulin and Platelet F4 in the blood are constant features of such condition.45 patients on long term anticoagulant treatment (thrombotest 5-10%),26 males(mean age 46) and 19 females(mean age 44), were studied. 22 normal sub jects served as controls.Platelets survival was studied with MDA production after 5oo mg Aspirin intake and was found signifi canly reduced in patients in comparison to contro Is(p.8.00±1.4 days;c.10.00±1.67 days; P<0.01).BTG and PF4 as measured by RIA were increased (BTG:p.97.8±59 NG/ML;c.29.18±22.40 NG/ML; P<0.01) (PF4:p.36.6±26.5 NG/ML;c.6.29±4.78 NG/ML; P<0.01) The patients were randomly allocated to one of the following groups( 15 subjects each): placebo, Suloctidil 600 mg:die, Suloctidil 1200 mg:die. Duration treatment was 30 days.The effect of Suloctidil was significantly different from that of placebo( P<0.005),as regards Platelet survival without difference between dosa ges of the drug;as concerns BTG and PF4 the chang es under placebo and drug were not different.

Sign in / Sign up

Export Citation Format

Share Document